Efficacy of fondaparinux for thromboprophylaxis in hip fracture patients

Journal of Arthroplasty

Volumn 19, Issue 7 SUPPL., 2004, Pages 78-81

  Eriksson, Bengt I ^a   Lassen, Michael R ^b   Colwell Jr , Clifford W ^c  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b Hoersholm Hospital   (Denmark)

^c SCRIPPS CLINIC   (United States)

Author keywords

extended prophylaxis; fondaparinux; hip fracture; venous thrombosis

Indexed keywords

FONDAPARINUX; PLACEBO;

AGED; BLEEDING; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SCREENING; HIGH RISK PATIENT; HIP FRACTURE; HUMAN; MAJOR CLINICAL STUDY; PHLEBOGRAPHY; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; STATISTICAL SIGNIFICANCE; VENOUS THROMBOEMBOLISM;

AGED; ANTICOAGULANTS; DOUBLE-BLIND METHOD; FEMALE; HIP FRACTURES; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; POLYSACCHARIDES; TREATMENT OUTCOME; VENOUS THROMBOSIS;

EID: 5344241891     PISSN: 08835403     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arth.2004.06.012     Document Type: Conference Paper

References (4)

1. Geerts W.H., Heit J.A., Clagett G.P., et al. Prevention of venous thromboembolism. Chest. 119:(Suppl 1):2001;132S
2. Eriksson B.I., Bauer K.A., Lassen M.R., Turpie A.G. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery. N Engl J Med. 345:2001;1298
3. Eriksson B.I., Lassen M.R. PENTasaccharide in Hip-Fracture Surgery Plus (PENTHIFRA Plus) investigators. Duration of prophylaxis against venous thromboembolism with fondaparinux after hip fracture surgery. Arch Intern Med. 163:2003;1337
4. Heit J.A., Silverstein M.D., Mohr D.N., et al. Risk factors for deep vein thrombosis and pulmonary embolism a population-based case-control study. Arch Intern Med. 160:2000;809